Filing Details

Accession Number:
0000899243-16-025726
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-07-26 17:14:57
Reporting Period:
2016-07-22
Filing Date:
2016-07-26
Accepted Time:
2016-07-26 17:14:57
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1374690 Zafgen Inc. ZFGN Pharmaceutical Preparations (2834) 203857670
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1611048 E. Thomas Hughes C/O Zafgen, Inc.
175 Portland Street, 4Th Floor
Boston MA 02114
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-07-22 25,000 $0.75 48,936 No 4 M Direct
Common Stock Acquisiton 2016-07-22 5,000 $3.02 53,936 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Acquisiton 2016-07-22 25,000 $0.00 25,000 $0.75
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
18,928 2018-12-15 No 4 M Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $3.015 to 3.04, inclusive. The reporting person undertakes to provide to Zafgen, Inc., any security holder of Zafgen, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
  2. Fully vested.
  3. Includes 2,276 shares acquired under Zafgen, Inc.'s 2014 Employee Stock Purchase Plan (the "Plan") on July 1, 2016, and 340 shares acquired under the Plan on January 1, 2016.